Efficacy and Safety of OnabotulinumtoxinA for Treatment of Moderate-to-Severe Forehead Lines

Main Article Content

Steve Fagien
Joel Cohen
William Coleman
Gary Monheit
Jean Caruthers
Cheri Mao
Domenico Vitarella
Xiaofang Lei
Bhushan Hardas


onabotulinumtoxinA, cosmetic, forehead lines, safety


Abstract Not Available
Study supported by Allergan.

Most read articles by the same author(s)